- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 295/26 - Atomes de soufre
Détention brevets de la classe C07D 295/26
Brevets de cette classe: 362
Historique des publications depuis 10 ans
34
|
32
|
21
|
19
|
23
|
16
|
19
|
25
|
13
|
12
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The Scripps Research Institute | 1347 |
16 |
The Regents of the University of California | 20015 |
14 |
FUJIFILM Corporation | 29489 |
9 |
Imago Biosciences, Inc. | 38 |
9 |
F. Hoffmann-La Roche AG | 7939 |
8 |
Canopy Growth Corporation | 221 |
8 |
Cytokinetics, Inc. | 280 |
8 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2861 |
7 |
H. Lundbeck A/S | 1252 |
7 |
Janssen Pharmaceutica N.V. | 3376 |
6 |
Board of Regents, The University of Texas System | 5828 |
6 |
University of Utah Research Foundation | 1814 |
6 |
3m Innovative Properties Company | 17813 |
5 |
Axikin Pharmaceuticals, Inc. | 14 |
5 |
Allergan Sales, LLC | 253 |
4 |
Emory University | 1625 |
4 |
Novira Therapeutics, Inc. | 32 |
4 |
Versitech Limited | 370 |
4 |
Genentech, Inc. | 3979 |
3 |
Centre National de La Recherche Scientifique | 10476 |
3 |
Autres propriétaires | 226 |